There's something fishy about this bleeding

NDT Plus

Volumn 4, Issue 4, 2011, Pages 270-272

  Berliner, Adam R ^a,b   Fine, Derek M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEPHROLOGY CENTER OF MARYLAND   (United States)

Author keywords

bleeding; omega 3 fatty acids; patient safety; platelet dysfunction; renal biopsy

Indexed keywords

CREATININE; OMEGA 3 FATTY ACID; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; EPISTAXIS; GINGIVA BLEEDING; HUMAN; KIDNEY BIOPSY; LUNG DYSPLASIA; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; RECIPIENT; UREA NITROGEN BLOOD LEVEL;

EID: 79961082238     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfr046     Document Type: Article

References (17)

1. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15: 142-147 (Pubitemid 38020705)
2. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002; 106: 2747-2757 (Pubitemid 35364932)
3. Fassett RG, Gobe GC, Peake JM et al. Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 2010; 56: 728-742
4. Thorngren M, Gustafson A. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 1981; 2: 1190-1193 (Pubitemid 12228352)
5. Thorngren M, Gustafson A. Effects of acetylsalicylic acid and dietary intervention on primary hemostasis. Am J Med 1983; 74: 66-71 (Pubitemid 13100782)
6. Pedersen HS, Mulvad G, Seidelin KN et al. N-3 fatty acids as a risk factor for haemorrhagic stroke. Lancet 1999; 353: 812-813 (Pubitemid 29110414)
7. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007; 99: 35C-43C
8. Engström K, Wallin R, Saldeen T. Effect of low-dose aspirin in combination with stable fish oil on whole blood production of eicosanoids. Prostaglandins Leukot Essent Fatty Acids 2001; 64: 291-297 (Pubitemid 32695300)
9. Harris WS. Expert opinion: Omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol 2007; 99: 44C-46C
10. Nye ER, Ablett MB, Robertson MC et al. Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty. Aust N Z J Med 1990; 20: 549-552
11. Peterson P, Hayes TE, Arkin CF et al. The preoperative bleeding time test lacks clinical benefit: College of American Pathologists' and American Society of Clinical Pathologists' position article. Arch Surg 1998; 133: 134-139 (Pubitemid 28092910)
12. Wolf DC, Weber F, Palascak I et al. Role of the template bleeding time in predicting bleeding complications of percutaneous liver biopsy [abstract]. Hepatology 1995; 22: 509A
13. Boberg KM, Brosstad F, Egeland T et al. Is a prolonged bleeding time associated with an increased risk of hemorrhage after liver biopsy? Thromb Haemost 1999; 81: 378-381 (Pubitemid 29116607)
14. Francis J, Francis D, Larson L et al. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice? Platelets 1999; 10: 132-136 (Pubitemid 29182281)
15. von Pape KW, Aland E, Bohner J. Platelet function analysis with PFA-100 in patients medicated with acetylsalicylic acid strongly depends on concentration of sodium citrate used for anticoagulation of blood sample. Thromb Res 2000; 98: 295-299 (Pubitemid 30255933)
16. Haubelt H, Anders C, Vogt A et al. Variables influencing platelet function analyzer-100 closure times in healthy individuals. Br J Haematol 2005; 130: 759-767 (Pubitemid 43906649)
17. Fressinaud E, Veyradier A, Truchaud F et al. Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases. Blood 1998; 91: 1325-1331 (Pubitemid 28086886)